Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

This study is ongoing, but not recruiting participants.

Study NCT00004067 Information provided by National Surgical Adjuvant Breast and Bowel Project (NSABP)

First Received: December 10, 1999 Last Updated: August 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2013
Primary Completion Date:	March 2005 (Final data collection date for primary outcome measure)